Ayahuasca: Ancient Ceremony
with Therapeutic Potential

Modern Clinical Evidence: Palhano-Fontes, de Almeida, dos Santos

Three pieces of research have substantially raised the credibility of ayahuasca as a therapeutic agent in the past decade. They are worth knowing by name because most online ayahuasca content makes claims that trace back to these specific papers, often without citation.

Palhano-Fontes 2019: The first ayahuasca RCT for depression

Palhano-Fontes et al. (2019, Psychological Medicine) conducted a randomized, placebo-controlled, double-blind trial of a single ayahuasca dose in 29 patients with treatment-resistant depression. Patients in the ayahuasca arm showed significant reductions in depression scores (MADRS, HAM-D) at days 1, 2, and 7 compared with placebo. By day 7, response rates were 64% for ayahuasca vs 27% for placebo, and remission rates were 36% vs 7%. This was the first parallel-arm RCT of any psychedelic for depression with positive results, predating the larger psilocybin trials.

de Almeida 2019: BDNF as a biological signature

de Almeida et al. (2019, Frontiers in Psychology) measured serum brain-derived neurotrophic factor (BDNF) in patients from the Palhano-Fontes cohort. Ayahuasca produced a significant increase in BDNF that correlated with depression score improvement. BDNF is implicated in neuroplasticity and is a common pathway across antidepressant mechanisms (SSRIs, ketamine, electroconvulsive therapy, exercise), so this provided a plausible biological bridge between the acute experience and lasting mood effects.

dos Santos 2018: Systematic review

dos Santos, Bouso, Alcázar-Córcoles and Hallak (2018, Therapeutic Advances in Psychopharmacology) reviewed all then-available clinical and observational data on ayahuasca, LSD, and psilocybin for mood and anxiety disorders. Their conclusion was cautious but positive: existing evidence supports further trials, with effect sizes comparable to or larger than standard antidepressants in short-term outcomes. The review is a useful reference because it situates ayahuasca within the broader psychedelic-therapy literature rather than treating it as exotic.

DMT and the Harmala Alkaloids: Why Ayahuasca Works Orally

Pure N,N-DMT is not orally active. Monoamine oxidase A (MAO-A) in the gut and liver rapidly degrades it. Ayahuasca solves this with a second ingredient: the vine Banisteriopsis caapi, which contains three beta-carboline alkaloids that inhibit MAO-A: harmine, harmaline, and tetrahydroharmine (THH).

• Harmine is the dominant alkaloid and a potent reversible MAO-A inhibitor. It allows the DMT from Psychotria viridis (chacruna) or Diplopterys cabrerina (chaliponga) to survive first-pass metabolism and reach the brain.
• Harmaline is structurally similar, more potent at MAO-A inhibition, and somewhat psychoactive on its own at higher doses.
• Tetrahydroharmine (THH) is a weaker MAO-A inhibitor but is also a serotonin reuptake inhibitor and may contribute to the longer-tail mood effects reported after ceremony.

The brew typically produces effects within 30 to 60 minutes of ingestion, with peak intensity around 90 minutes and total duration of 4 to 6 hours. DMT itself has a half-life of roughly 15 minutes in plasma; the harmalines extend the active window dramatically by blocking its breakdown.

La Dieta: Tradition and Pharmacological Logic

Indigenous ayahuasca preparation traditions include a pre-ceremony dieta: avoidance of pork, aged cheeses, fermented foods, alcohol, recreational drugs, and sexual activity in the days or weeks before drinking. Western seekers sometimes dismiss this as superstition. The pharmacological reality is the opposite: the dieta is consistent with what modern pharmacology now knows about MAO-A inhibition.

The harmalines in ayahuasca are reversible MAO-A inhibitors. MAO-A degrades tyramine, a biogenic amine found in aged, fermented, and cured foods (aged cheese, salami, soy sauce, fermented bean curd, fava beans, broad beans). With MAO-A inhibited, dietary tyramine can accumulate and trigger a hypertensive crisis (the so-called “cheese reaction” familiar from older MAOI antidepressants like phenelzine). Avoiding these foods before and immediately after ceremony is medically prudent, not superstition.

Dangerous Interactions: SSRIs, MAO Inhibitors, Stimulants

The single most common life-threatening ayahuasca scenario is serotonin syndrome from combining the brew with a prescribed SSRI or SNRI. People on antidepressants who decide to attend ceremony without telling the facilitator are taking a serious and avoidable risk. Specific contraindications:

• SSRIs and SNRIs (fluoxetine, sertraline, paroxetine, citalopram, escitalopram, venlafaxine, duloxetine): elevated serotonin syndrome risk. Most ceremonial traditions require a washout of 4 to 6 weeks (8 weeks for fluoxetine because of its long half-life). This is a medical decision and should not be done without psychiatric supervision.
• MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid, moclobemide, selegiline): additive MAO-A inhibition can produce severe hypertensive crisis and serotonin syndrome. Absolute contraindication.
• Stimulants and sympathomimetics (amphetamines, MDMA, cocaine, decongestants containing pseudoephedrine): tyramine-like reactions, hypertensive crisis.
• Tramadol, dextromethorphan, meperidine, lithium: serotonergic and dangerous in combination with MAO-A inhibition.
• Cardiovascular disease: untreated hypertension, ischemic heart disease, recent cardiac event, severe arrhythmia. The acute blood pressure spike during ceremony is significant.
• Personal or first-degree family history of psychotic disorders: schizophrenia, schizoaffective disorder, bipolar I.
• Pregnancy: insufficient safety data; standard recommendation is to avoid.

Religious Use Exemptions and the Gonzales v. UDV Decision

The international legal status of ayahuasca is a patchwork. The Convention on Psychotropic Substances of 1971 scheduled pure DMT but did not list plants containing DMT, leaving brewing in legal grey territory in many countries.

The 2006 US Supreme Court decision in Gonzales v. O Centro Espírita Beneficente União do Vegetal (the UDV case) is the foundational legal precedent in the United States. The court ruled unanimously that the federal government had not demonstrated a compelling interest in barring the UDV, a Brazilian-rooted syncretic religion, from importing and using ayahuasca in religious ceremonies, under the Religious Freedom Restoration Act. A subsequent settlement extended similar protection to the Santo Daime church. These rulings created a narrow religious-exemption pathway in US law that does not extend to secular or independent ceremonies.

In Brazil and Peru, ayahuasca use in established religious and traditional contexts is legal. In most of Europe, importation of the prepared brew remains prosecutable. The Netherlands prosecuted and acquitted Santo Daime cases in the 2000s but has since prosecuted other groups; the legal terrain shifts. Israel currently treats DMT-containing preparations as Schedule I narcotics with no exemption.

Set and Setting: Ceremony vs Clinical Container

Modern psychedelic-assisted therapy borrowed the phrase “set and setting” from Timothy Leary, who in turn borrowed the underlying principle from indigenous ceremonial practice. In the ayahuasca context the container is highly structured: a maloca or ceremony space, a curandero or facilitator who leads the work, icaros (medicine songs) sung throughout the night, fellow participants, and a careful integration period in the following days.

The clinical-trial container is structured differently: a private room, a therapist dyad, eyeshades, curated music, and structured preparation and integration sessions. Both are containers; neither is neutral. The work many people do after ceremony is recognizing that the experience was shaped by both the pharmacology and the structure around it. Our psychedelics hub walks through the difference in more depth.

Integration Through the Micro-Movement Somatic Lens

The hardest part of psychedelic work is rarely the ceremony itself. It is the weeks and months that follow, when insight has to translate into changed behavior in an unchanged life. The Micro-Movement Method approach to integration leans on somatic practice: slow, deliberate body-based work designed to keep the nervous-system shifts that ceremony opens from collapsing back to baseline.

Practical integration tools we teach include daily somatic check-ins, breath-paced movement to regulate autonomic state, journaling structured around body sensation rather than narrative, and avoiding the temptation to immediately re-dose. Integration done well makes the next ceremony unnecessary or, at least, qualitatively different.

Return to the psychedelics hub

Botany: The Vine and the Leaf

The ayahuasca brew at its core is two plants. The vine, Banisteriopsis caapi, supplies the harmala alkaloids that make DMT orally active. The DMT itself most often comes from the leaves of Psychotria viridis (chacruna) in the Peruvian and Brazilian traditions, or from Diplopterys cabrerana (chaliponga or chagropanga) in the Ecuadorian and Colombian traditions. The two leaves are not interchangeable: chaliponga tends to produce a sharper, more visual experience because it also contains 5-MeO-DMT in some specimens, whereas chacruna yields a brew dominated by N,N-DMT.

The vine alone, drunk without DMT-containing leaves, produces a quieter experience often described as introspective, somewhat sedating, and dream-like. Some indigenous traditions distinguish between vine-only “caapi” and full leaf-and-vine “ayahuasca” preparations, using them for different purposes.

Traditional Brewing Method

A traditional preparation involves pounding the vine, layering it with leaves in a large pot, covering with water, and simmering for many hours, often a full day, sometimes longer. The brew is reduced, strained, re-cooked, and concentrated. The taste is widely described as one of the most unpleasant substances anyone willingly drinks: bitter, earthy, viscous, with a metallic finish. The viscosity makes it difficult to drink quickly, which compounds the gag reflex many participants experience.

The nausea and purging (la purga: vomiting and sometimes diarrhea) that follow are considered part of the medicine in traditional contexts, not a side effect to be suppressed. Whether one frames it as cleansing or as a peripheral 5-HT receptor effect from the harmalas, the purge typically arrives within an hour of drinking and is often associated with emotional release.

What the Experience Looks Like Hour by Hour

• 0 to 30 minutes after drinking. Body changes: warmth, mild dizziness, often pronounced nausea. Closed-eye visuals may begin, often as faint geometric patterns or gentle color shifts.
• 30 to 60 minutes. Onset intensifies. Many people purge in this window. Visuals deepen, often described as feeling pulled inward, into intricate, organic, sometimes architectural visions. Emotional material can surface abruptly.
• 1 to 3 hours. Peak. The work of the ceremony. Icaros (medicine songs sung by curanderos) shape and guide the experience. Themes of ancestry, grief, fear, love, and meaning are common. Time perception becomes elastic or absent.
• 3 to 5 hours. Gradual descent. Visuals soften. Reflective clarity returns. Some sit silently with what surfaced; others fall into the deep, dreamlike rest characteristic of the late phase.
• Following day. Afterglow with elevated mood and clarity is common, alongside fatigue. Integration begins immediately, whether one is aware of it or not.

Trauma Activation: When Ayahuasca Goes Sideways

The most common psychological adverse event in ayahuasca ceremony is not a psychotic break (rare) but trauma reactivation that the participant and the container are not equipped to hold. People with complex trauma histories sometimes find that ayahuasca opens material faster than their nervous system can process. The result can be acute distress during the ceremony, dissociation in the days after, or a slow-burn destabilization over weeks.

Responsible facilitators screen for trauma history, ask about prior somatic and psychological work, and have a plan for difficult passages: physical presence, breath coaching, sometimes ending the night early. The major warning sign in any retreat or ceremony is a facilitator who frames difficult experiences as “the medicine doing its work” without offering real-time support or a plan for integration. That framing can be true and is sometimes correct; it is also frequently a euphemism for absence of skill.

Extended Contraindications and Drug Interactions

Beyond the headline categories (SSRIs, MAOIs, stimulants), several less-discussed interactions warrant attention:

• Tricyclic antidepressants (amitriptyline, nortriptyline, imipramine): serotonergic and risky.
• Bupropion (Wellbutrin): lowers seizure threshold; complicates the picture.
• Lithium: pairing with serotonergic agents has been linked to seizures and serotonin syndrome.
• St. John’s Wort: serotonergic, often overlooked because it is a herbal.
• 5-HTP and L-tryptophan supplements: serotonin precursors; same risk class.
• Triptans (sumatriptan for migraine): serotonergic.
• Dextromethorphan (in many cough syrups): serotonergic and dissociative.
• MDMA in the days before ceremony: depletes serotonin transiently and can flatten the ayahuasca experience or in some cases destabilize the nervous system.
• Recent stimulant use (amphetamines, methylphenidate, cocaine): risk of hypertensive crisis from tyramine-like sympathomimetic activity combined with MAO-A inhibition.
• Alcohol: avoid for several days before and after; both for safety and for the dieta tradition.

The single most important step before any ceremony is a full medication and supplement disclosure to the facilitator, including over-the-counter products. If a facilitator does not ask, that is itself diagnostic.

The Syncretic Religions: Santo Daime and UDV

Two Brazilian religious movements have shaped ayahuasca’s modern legal and cultural status. Santo Daime, founded by Raimundo Irineu Serra in the 1930s in the Brazilian Amazon, blends Catholicism, African spirit traditions, and indigenous shamanism, with the brew (called daime) as the central sacrament. The Uniao do Vegetal (UDV), founded by Jose Gabriel da Costa in 1961, also uses ayahuasca (called hoasca) in structured religious services, with a doctrinal framework emphasizing Christian themes.

Both religions have spread internationally and both have fought legal battles in the United States and Europe. The 2006 Gonzales v. UDV Supreme Court decision is the foundational US precedent. Subsequent settlements and court rulings have extended legal recognition to Santo Daime branches in several US districts. These rulings carve narrow religious-exemption pathways that do not extend to secular retreat centers, “shamanic” workshops outside an established religious tradition, or individual independent use.

La Dieta: Beyond Cheese and Cured Meat

The traditional dieta extends beyond the tyramine-avoidance pharmacology. In master plant traditions, dieta refers to an extended period (weeks to months) in which a practitioner consumes only a restricted set of foods (often boiled plantain, fish, rice) and abstains from sex, alcohol, recreational substances, salt, sugar, pork, and aged foods, while drinking small amounts of a single master plant (a doctor plant) under the guidance of a curandero. The aim is to develop a relationship with that plant’s spirit and to receive its teachings.

From a modern pharmacological view this looks like a combination of nutritional simplification, tyramine avoidance, sensory and social withdrawal, and consistent low-dose plant exposure. From an indigenous view it is a structured initiation. Both framings can be held simultaneously without contradiction.

Integration Practices in Detail

Integration is the work of turning insight into life. The first 48 hours after ceremony are often a window of unusual openness; the first two weeks are a period of nervous-system recalibration; the first three months are when behavioral change either sticks or dissolves.

Concrete integration practices we teach in the Micro-Movement framework include:

• Daily somatic check-ins. Two to five minutes, eyes closed, scanning attention through the body without trying to change anything. The goal is to maintain contact with the embodied sense that ceremony often opens.
• Breath-paced movement. Slow yoga, qigong, or walking with attention to breath. Avoid intense cardio or weight training in the week after ceremony; the nervous system is still recalibrating.
• Journaling with somatic anchoring. Write what surfaces, then describe where you feel it in the body. The body anchor prevents the mind from converting insight into a tidy story too quickly.
• Restraint on re-dosing. A common pattern is to want another ceremony within weeks. Resist. Integration is the work; another ceremony before integration completes is often a way to avoid that work.
• Therapeutic support if available. A therapist familiar with psychedelic integration is ideal. A skilled somatic-experiencing or IFS practitioner without psychedelic-specific training is often nearly as good. A therapist who pathologizes the experience itself is worse than none.

A Note on Adjacent Practices: Kambo, San Pedro, Bufo

Many retreat centers combine ayahuasca with other indigenous practices: kambo (frog secretion applied to small skin burns, used emetically), San Pedro or huachuma (mescaline-containing cactus), and 5-MeO-DMT from Bufo alvarius toad secretion. Each carries its own risk profile and cultural context. Stacking these in a single retreat amplifies both potential benefit and potential destabilization. Discuss any combined-medicine offering with the facilitator in detail before committing.

Common Questions People Bring to Their First Ceremony

How many ceremonies should I attend?

Most experienced facilitators recommend a series of two to four nights over a single retreat, with several months of integration before considering returning. A single ceremony can produce real change if the integration work is thorough. Stacking dozens of ceremonies over a short period is a pattern that often signals avoidance rather than therapeutic progress.

What if nothing happens on my first ceremony?

This is common and almost always reflects either an underdose for that person’s metabolism, an antidepressant or supplement that blunted the effect, or a particularly defended psychological state. Most retreats offer follow-up nights at the same retreat for this reason. Pushing for very high doses to “feel something” is a common error and risks a destabilizing experience the participant is not prepared for.

Can I drink ayahuasca while taking lithium or anticonvulsants?

No. The lithium combination has been associated with seizures and serotonin syndrome. Anticonvulsants like lamotrigine carry their own profile. Discontinuing these requires psychiatric supervision and is not a decision the retreat can make on the participant’s behalf.

How long does the afterglow last?

For most participants, the immediate afterglow runs three to seven days, with elevated mood, reduced anxiety, increased social warmth, and clearer thinking. The deeper integration window, when behavioral changes can stick more easily than at baseline, extends roughly two to four weeks. After that, ordinary life resumes its gravitational pull and the participant either has built new structures or returns to baseline.

Is online ayahuasca legitimate?

No. Drinking ayahuasca alone or with a remote video facilitator is not a substitute for in-person ceremony. The risk of acute distress, autonomic crisis, or unsafe environment without skilled physical presence is significant. This applies to all dosing levels; “microdosing” ayahuasca remotely is also not a recognized therapeutic protocol.

What about retreats that combine ayahuasca with other practices?

Common combinations include kambo (frog secretion ordeal medicine), San Pedro or huachuma cactus (mescaline), 5-MeO-DMT (Bufo toad), tobacco purges, and various plant baths. Each adds its own profile to the week. We generally recommend a participant’s first encounter with any one of these be in isolation, not stacked, so that integration work can focus on a single medicine. Retreats that pile five medicines into a single week are optimizing for intensity rather than therapeutic outcome.